Authors
Latest:
Delays in Psychiatric Care: New Hampshire’s Robust ResponseNew Hampshire’s mental health system faces ongoing challenges with emergency department boarding, legal concerns over due process, and resource shortages, prompting reforms to improve patient care and access.
Latest:
Seltorexant, Major Depressive Disorder, and Insomnia: Thoughts on the New DataAndrew Krystal, MD, and Wayne Drevets, MD, share their thoughts on the recent seltorexant data presented at the 2024 ASCP Annual Meeting.
Latest:
RE104: A Novel, Fast-Acting Psychedelic for Postpartum DepressionExperts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.
Latest:
RE104: A Novel, Fast-Acting Psychedelic for Postpartum DepressionExperts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.
Latest:
SUDs in Women and the Importance of Tailored Treatment ApproachesWhat are the most effective approaches to SUD treatment in this unique patient population?
Latest:
Let’s Build Brains Better! Brain Science-Inspired Policies for the FutureIn order to face the rapidly changing, increasingly complex, and globally connected world, we need to focus on the importance of early brain and child development.
Latest:
Psychopathy: Insights for General PracticeWhile incarceration is the definitive “treatment” for some, psychopathy exists on a spectrum like any other mental disorder; more recent research suggests the condition is capable of responding to treatment.
Latest:
Resiliency and Posttraumatic Growth: Cultural Implications for PsychiatristsAcknowledging a patient's ability to grow and recover may help them feel more understood despite ongoing suffering.
Latest:
Adding Insult to Narcissistic Injury: Comorbidity of Narcissistic Personality Disorder and Major Depressive DisorderDiagnosing this intricate comorbidity demands a nuanced approach. Here's what you need to know.
Latest:
Zuranolone for the Treatment of Adults With Major Depressive DisorderThis randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.
Latest:
Female Offenders: Patterns, Risk, and AssessmentFemale offenders in the criminal justice system are more likely to have experienced trauma and are more likely to be diagnosed with conditions such as PTSD and depression compared with male offenders.
Latest:
SPIRIT (Social Psychiatry Interested in Recovery from International Trauma) Voices Some Current ConcernsAll these events that occurred over the weekend bear social psychiatric weight.
Latest:
Brain Capital: An Emerging Investment OpportunityBrain Capital: a fresh approach to technologies and investing.
Latest:
Opportunities in Managing Treatment-Resistant Depression and Tardive DyskinesiaThis CME describes current strategies and recent advances in treatment.
Latest:
Physician Liability During COVID-19: What You Need to Know To Protect Your PracticeDoes the typical malpractice insurance policy cover COVID-related claims? That question and more answered.
Latest:
New-Onset Racism or Psychosis?Racism is not usually considered a psychotic symptom and therefore it is not often considered in the diagnosis of schizophrenia.
Latest:
Exploring Diagnostic Strategies in the Assessment of Mixed Affective StatesIn this CME article, examine how current DSM nosology defines the proper method of assessing a mixed-episode patient and which diagnostic labels to give them based on their presenting symptomatology.
Latest:
Finding Joy in Life: A Psychiatric PerspectiveDiscover how Tiffani Bell Washington, MD, MPH, FAPA, inspires joy and balance in busy lives, combating burnout and redefining wellness for high-achieving women.
Latest:
Social Psychiatry and Culturally Relevant Psychotherapy at the APA Annual MeetingVincenzo Di Nicola discusses the importance of pluralism in social psychiatry and the need for culturally relevant psychotherapy at the 2025 APA Annual Meeting.
Latest:
Brain Capital: An Emerging Investment OpportunityBrain Capital: a fresh approach to technologies and investing.
Latest:
What Does the Future Hold for Psychedelic-Assisted Psychotherapy?A growing body of scientific evidence suggests that mind-altering drugs, combined with psychotherapy, are effective treatments for some of the most stubborn psychiatric disorders.
Latest:
The Ethics of ReopeningAt the heart of reopening is protecting both population health and economic health.
Latest:
Market Yourself by Leveraging Digital PlatformsHaving an appropriate presence on social media can help your career.
Latest:
You Say Pain. I Say Addiction. Let’s Call the Whole Thing OffThis CME will inform clinicians with unique and much-needed skill sets in diagnosing substance use disorders and managing co-occurring chronic pain.
Latest:
Chemotherapy-Induced Psychosis in an AdolescentCheck out this case study to learn more about how viral infections might play a role in triggering psychotic disorders.
Latest:
10 Measures and Outcomes to Assess Progress in Eradicating RacismSuggestions to assess outcomes and measure success levels in combatting racism.
